Related Experiment Video
Updated: Jul 17, 2026

11:36
Voxel Printing Anatomy: Design and Fabrication of Realistic, Presurgical Planning Models through Bitmap Printing
Published on: February 9, 2022
Three-Dimensional Printing in Trichology: A Narrative Mini-Review - Where Are We Now?
Fernanda Múnera Yamhure1, Ramon Grimalt1
1Department of Dermatology, Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona, Spain.
Skin Appendage Disorders
|July 16, 2026
Summary
Three-dimensional (3D) bioprinting offers a promising new approach to treating alopecia by creating artificial hair follicles. While still in preclinical stages, this technology has potential applications in hair loss treatment and regenerative medicine.
Area of Science:
- Bioengineering and Regenerative Medicine
- Bioprinting Technologies
- Trichology Research
Background:
- Alopecia is a widespread condition with limited traditional treatment options.
- Emerging bioengineering strategies, including 3D bioprinting, aim to address these limitations.
- 3D bioprinting seeks to create functional hair follicles de novo.
Purpose of the Study:
- To review the materials, processes, applications, and limitations of 3D bioprinting in trichology.
- To explore the use of synthetic and natural polymers in bioinks for hair follicle bioprinting.
- To discuss the potential of 3D bioprinting for treating alopecia and other applications.
Main Methods:
- Review of current literature on 3D bioprinting for hair follicle regeneration.
- Identification of polymers used in bioink formulations.
- Analysis of cell layering techniques for creating dermal and epidermal structures.
- Exploration of applications in androgenetic alopecia and wound healing.
Main Results:
- Various synthetic and natural polymers are utilized as bioinks for 3D bioprinting hair follicles.
- The process involves layering cell populations, primarily dermal papilla cells, to construct hair follicle structures.
- Potential applications include treating androgenetic alopecia, wound healing, surgical templating, and reducing animal testing.
- Current limitations include high maintenance costs, balancing cell viability with printability, and lack of human clinical application.
Conclusions:
- 3D bioprinting is a promising preclinical strategy for alopecia treatment.
- The technology offers versatility for personalized medicine, surgical guidance, and research.
- Further optimization of bioinks and cost reduction are necessary for clinical translation.
